EudraVigilance Veterinary

Human medicines European public assessment report (EPAR): Cufence, trientine dihydrochloride, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - May 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 19 May 2025, 15:00 (CEST) to 19 May 2025, 16:00 (CEST)

Network Data Steering Group workplan 2025-2028

Human medicines European public assessment report (EPAR): Stivarga, regorafenib, Date of authorisation: 26/08/2013, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 8, Status: Authorised

Healthcare professionals: Key documents

EMA/FVE info session for veterinary practitioners: Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2025, 15:30 (CEST) to 3 June 2025, 16:30 (CEST)

Human medicines European public assessment report (EPAR): Busulfan Fresenius Kabi, busulfan, Date of authorisation: 22/09/2014, Revision: 11, Status: Authorised

Minutes of the COMP meeting 13-15 May 2025